Symptom Severity and QOL Scales for Urinary Incontinence

Gastroenterology

Volumn 126, Issue 1, 2004, Pages

  Naughton, Michelle J ^a,i   Donovan, Jenny ^b   Badia, Xavier ^c   Corcos, Jacques ^d   Gotoh, Momokazu ^e   Kelleher, Con ^f   Lukacs, Bertrand ^g   Shaw, Christine ^h  

^a WAKE FOREST UNIVERSITY   (United States)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c Walgreens Health Services   (Spain)

^d MCGILL UNIVERSITY   (Canada)

^e NAGOYA UNIVERSITY   (Japan)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g University Wales College of Medicine ^*

^h CARDIFF UNIVERSITY   (United Kingdom)

ⁱ WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; DISEASE SEVERITY; FUNCTIONAL ASSESSMENT; HEALTH STATUS; HUMAN; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; SCORING SYSTEM; SELF REPORT; SYMPTOM; URETHRA DISEASE; URGE INCONTINENCE; URINE INCONTINENCE; URODYNAMICS; VALIDATION PROCESS;

EID: 0347362563     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2003.10.059     Document Type: Conference Paper

References (79)

1. Boyarsky S, Jones G, Paulson DF, Prout GR. New look at bladder neck obstruction by the Food and Drug Administration regulators. Am Assoc Genitourinary Surg 1977;68:29-32.
2. Korman HJ, Sirls LT, Kirkemo AK. Success rate of modified Pereyra bladder neck suspension determined by outcomes analysis. J Urol 1994;152:1453-1457.
3. Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory W. Who should measure quality of life, the doctor or the patient? Cancer 1988; 57:109-112.
4. Coscarrelli-Schag C, Heinrich RL, Ganz PA. Karnofsky performance status revisited: reliability, validity and guidelines. J Clin Oncol 1984;2:187-193.
5. Hutchinson TA, Boyd NF, Feinstein AR. Scientific problems in clinical scales. J Chronic Dis 1979;32:661-666.
6. Pearlman RA, Uhlmann RF. Quality of life in chronic diseases: perceptions of elderly patients. J Gerontol 1988;43:M25-M30.
7. Wyman JF, Choi SC, Harkins SW, Wilson MS, Fantl AJ. The urinary diary in evaluation of incontinent women: a test-retest analysis. Obstet Gynecol 1988;71:812-817.
8. Barnick C. Frequency volume chart. In: Cardozo L, ed. Urogynaecology. London: Churchill Livingstone, 1997:105-107.
9. Follick M, Ahern D, Laser-Wolston N. Evaluation of a daily activity diary for chronic low back pain. Pain 1984;19:373-382.
10. de la Rosette JJMC, Witjes WPJ, Schäfer W, Abrams P, Donovan JL, Peters TJ, Millard RJ, Frimodt-Moller C, Kalomiris P. Relationships between lower urinary tract symptoms and bladder outlet obstruction: results from the ICS-BPH study. Neurourol Urodyn 1998;17:99-108.
11. Barry MJ, Cockett ATK, Holtgrewe HL, McConnell JD, Sihelnik SA, Winfield HN. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol 1993;150:351-358.
12. el Din KE, Koch WF, de Wildt MJ, Kiemeney LA, Debruyne FM, de la Rossette JJ. Reliability of the International Prostate Symptom Score in the assessment of patients with lower urinary tract symptoms and/or benign prostatic hyperplasia. J Urol 1996;155: 1959-1964.
13. Reynard JM, Yang Q, Donovan JL, Peters TJ, Schäfer W, de la Rosette JJ, Dabhoiwala NF, Osawa D, Lim AT, Abrams P. The ICS-"BPH" study: uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction. Br J Urol 1998;82:619-623.
14. Norton C. The effects of urinary incontinence in women. Int Rehabil Med 1982;4:9-14.
15. Hunskaar S, Vinsnes A. The quality of life in women with urinary incontinence as measured by the sickness impact profile. J Am Geriatr Soc 1991;39:378-382.
16. Uebersax JS, Wyman JF, Shumaker SA, McClish DK, Fantl AJ. Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Neurourol Urodyn 1995;14:131-139.
17. Wyman JF, Harkins SW, Taylor JR, Fantl JA. Psychosocial impact of urinary incontinence in women. Obstet Gynecol 1987;70:378-381.
18. Donovan JL, Naughton M, Gotoh M, Corcos J, Jackson S, Kelleher C, Lukacs B, Costa P. Symptom and quality of life assessment. In: Abrams P, Khoury S, Wein AJ, eds. Incontinence. Plymouth, UK: Health Publication Ltd, 1999:295-331.
19. Donovan JL, Badia X, Corcos J, Gotoh M, Kelleher C, Naughton M, Shaw C, Lukacs B. Symptom and quality of life assessment. In: Abrams P, Cardozo L, Khoury S, Wein AJ, eds. Incontinence. Plymouth, UK: Health Publication Ltd, 2002:267-316.
20. Corcos J, Beaulieu S, Donovan J, Naughton M, Gotoh M. Quality of life assessment in men and women with urinary incontinence. J Urol 2002;168:896-905.
21. Shumaker SA, Wyman JF, Uebersax JS, McClish D, Fantl JA. Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Qual Life Res 1994;3:291-306.
22. Lubeck DP, Prebil LA, Peeples P, Brown JS. A health related quality of life measure for use in patients with urge urinary incontinence: a validation study. Qual Life Res 1999;8:337-344.
23. Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 1997;104:1374-1379.
24. Sandvik H, Hunskaar S, Seim A, Hermstad R, Vanvik A, Bratt H. Validation of a severity index in female urinary incontinence and its implementation in an epidemiological survey. J Epidemiol Community Health 1993;47:497-499.
25. Hald T, Nordling J, Andersen JT, Bilde T, Meyhoff HH, Walter S. A patient weighted symptom score system in the evaluation of uncomplicated benign prostatic hyperplasia. Scand J Urol Nephrol Suppl 1991;138:59-62.
26. Donovan JL, Abrams P, Peters TJ, Kay HE, Reynard J, Chapple C, de la Rosette JJ, Kondo A. The ICS-"BPH" Study: the psychometric validity and reliability of the ICSmale questionnaire. Br J Urol 1996;78:554-562.
27. Donovan JL, Peters TJ, Abrams P, Brookes ST, de la Rosette JJ, Schäfer W. Scoring the ICSmaleSF questionnaire. J Urol 2000;164:1948-1955.
28. Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank L, Abrams P. The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing. Br J Urol 1996;77:805-812.
29. Black N, Griffiths J, Pope C. Development of a symptom severity index and a symptom impact index for stress incontinence in women. Neurourol Urodyn 1996;15:630-640.
30. Robinson D, Pearce K, Preisser J, Dugan E, Suggs P, Cohen S. Relationship between patient reports of urinary incontinence symptoms and quality of life measures. Obstet Gynecol 1998; 91:224-228.
31. Dugan E, Cohen SJ, Robinson D, Anderson R, Preisser J, Suggs P, Pearce K, Poehling U, McGann P. The quality of life of older adults with urinary incontinence: determining generic and condition specific predictors. Qual Life Res 1998;7:337-344.
32. Gordon E, Stanton S. Urinary incontinence in elderly women. Eur Urol 1998;33:241-247.
33. Lemack GE, Zimmern PE. Predictability of urodynamic findings based on the Urogenital Distress Inventory-6 questionnaire. Urology 1999;54:461-466.
34. Blanc E, Hermieu JF, Ravery V, Moulinier F, Delmas V, Boccon-Gibod L. Value of the use of a questionnaire in the evaluation of incontinence surgery. Prog Urol 1999;9:88-94.
35. Brown JS, Posner S, Stewart AL. Urge incontinence: new health-related quality of life measures. J Am Geriatr Soc 1999;47:980-988.
36. Hanley J, Capewell A, Hagen S. Validity study of the severity index, a simple measure of urinary incontinence in women. BMJ 2001;322:1096-1097.
37. Meyhoff HH, Hald T, Nordling J, Andersen JT, Bilde T, Walter S. A new patient weighted symptom score system (DAN-PSS-1). Clinical assessment of indications and outcomes of transurethral prostatectomy for uncomplicated benign prostatic hyperplasia. Scand J Urol Nephrol 1993;27:493-499.
38. Hansen BJ, Flyger H, Brasso K, Schou J, Nordling J, Thorup Andersen J, Mortensen S, Meyhoff HH, Walter S, Hald T. Validation of the self-administered Danish Prostatic Symptom Score (DAN-PSS-1) system for use in benign prostatic hyperplasia. Br J Urol 1995;76:451-458.
39. Abrams P, Donovan JL, de la Rosette JJ, Schäfer W. International Continence Society "Benign Prostatic Hyperplasia" Study: background, aims, and methodology. Neurourol Urodyn 1997;16:79-91.
40. Donovan JL, Brookes ST, de la Rosette JJ, Peters TJ, Porru D, Kondo A, Dabhoiwala N, Millard R, Bosch R, Nordling J, Matos Ferreira A, Hofner K, Mostafid H, Walter S, Nissenkorn I, Frimodt Moiler C, Mendes Silva M, Chapple C, Abrams P. The responsiveness of the ICSmale questionnaire to outcome: evidence from the ICS-"BPH" study. BJU Int 1999;83:243-248.
41. Temml C, Haidinger G, Schmidbauer J, Schatzl G, Madersbacher S. Urinary incontinence in both sexes: prevalence rates and impact on quality of life and sexual life. Neurourol Urodyn 2000; 19:259-271.
42. Naughton MJ, Shumaker SA. Assessment of health-related quality of life. In: Furberg CD, ed. Fundamentals of clinical trials. St. Louis: Mosby, 1997:185.
43. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
44. The EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
45. Bergner M, Bobbett RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981;19:787-805.
46. Hunt SM, McEwen J, McKenna SP. Measuring health status: a new tool for clinicians and epidemiologists. J R Coll Gen Pract 1985;35:185-188.
47. Sullivan M, Karlsson J, Bengtsson C, Furunes B, Lapidus L, Lissner L. "The Göteborg Quality of Life Instrument"-a psychometric evaluation of assessments of symptoms and well-being among women in a general population. Scand J Prim Health Care 1993;11:267-275.
48. Hunter JW, McKee M, Black NA, Sanderson CF. Health status and quality of life of British men with lower urinary tract symptoms: results from the SF-36. Urology 1995;45:962-971.
49. Donovan JL, Kay HE, Peters TJ, Abrams P, Coast J, Matos-Ferreira A, Rentzhog L, Bosch JL, Nordling J, Gajewski JB, Barbalias G, Schick E, Silva MM, Nissenkorn I, de la Rosette JJ. Using ICSQoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-"BPH" Study. International Continence Society-Benign Prostatic Hyperplasia. Br J Urol 1997;80: 712-721.
50. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40-66.
51. Mozes B, Maor Y, Shmueli A. The competing effects of disease states on quality of life of the elderly: the case of urinary symptoms in men. Qual Life Res 1999;8:93-99.
52. Schlenk EA, Erlen JA, Dunbar-Jacob J, McDowell J, Engberg S, Sereika SM, Rohay JM, Bernier MJ. Health-related quality of life in chronic disorders: a comparison across studies using the MOS SF-36. Qual Life Res 1998;7:57-65.
53. Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, Westlake L. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992; 305:160-164.
54. Jenkinson C, Lawrence K, McWhinnie D, Gordon J. Sensitivity to change of health status measures in a randomized controlled trial: comparison of the COOP charts and the SF-36. Qual Life Res 1995;4:47-52.
55. Gliklich RE, Hilinski JM. Longitudinal sensitivity of generic and specific health measures in chronic sinusitis. Qual Life Res 1995;4:27-32.
56. Epstein RS, Deverka PA, Chute CG, Panser L, Oesterling JE, Lieber MM, Schwartz S, Patrick D. Validation of a new quality of life questionnaire for benign prostatic hyperplasia. J Clin Epidemiol 1992;45:1431-1445.
57. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, Brook RH. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995;273:129-135.
58. Sand PK, Richardson DA, Staskin DR, Swift SE, Appell RA, Whitmore KE, Ostergard DR. Pelvic floor electrical stimulation in the treatment of genuine stress incontinence: a multicenter, placebo-controlled trial. Am J Obstet Gynecol 1995;173:72-79.
59. Ware J, Kosinski M, Keller S. SF-36 physical and mental health summary scales: a user's manual, Boston: Medical Outcomes Trust, 1994.
60. Chiarelli P, Brown W, McElduff P. Leaking urine: prevalence and associated factors in Australian women. Neurourol Urodyn 1999; 15:567-577.
61. Mishra G, Schofield MJ. Norms for the physical and mental health component summary scores of the SF-36 for young, middle-aged and older Australian women. Qual Life Res 1998;7:215-220.
62. Emberton M, Neal DE, Black N, Fordham M, Harrison M, McBrien MP, Williams RE, McPherson K, Devlin HB. The effect of prostatectomy on symptom severity and quality of life. Br J Urol 1996; 77:233-247.
63. Brooks R. EuroQol: the current state of play. Health Policy 1996; 37:53-72.
64. Kobelt G. Economic considerations and outcome measurement in urge incontinence. Urology 1997;50(6A):100-107.
65. Fuertes ME, Garcia Matres MJ, Gonzales Romajaro V, de la Rosa S, Anguera Vila A, de la Pena J, Leiva Galvis O, Sanchez Chapado M. Clinical trial to evaluate trospium chloride (Uraplex) effectiveness and tolerance in patients with detrusor instability incontinence and its impact on quality of life. Arch Esp Urol 2000;53: 125-136.
66. Anderson RT, Aaronson NK, Wilkin D. Clinical review of the international assessments of health-related quality of life. Qual Life Res 1993;2:369-395.
67. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981;19:787-805.
68. Grimby A, Milsom I, Molander U, Wiklund I, Ekelund P. The influence of urinary incontinence on the quality of life of elderly women. Age Ageing 1993;22:82-89.
69. Hunt SM, McKenna SF, McEwer J. A quantitative approach to perceived health. J Epidemiol Community Health 1980;34:281-285.
70. Samuelsson E, Victor A, Tibblin G. A population study of urinary incontinence and nocturia among women aged 20-59 years. Prevalence, well-being and wish for treatment. Acta Obstet Gynecol Scand 1997;76:74-80.
71. Wagner TH, Patrick DL, Bavendam TG, Martin ML, Buesching DP. Quality of life of persons with urinary incontinence: development of a new measure. Urology 1996;47:67-72.
72. Wyman JF, Harkins SW, Choi SC, Taylor JR, Fantl JA. Psychosocial impact of urinary incontinence in women. Obstet Gynecol 1987; 70:378-381.
73. Fleshner N, Herschorn S. The artificial urinary sphincter for postradical prostatectomy incontinence: impact on urinary symptoms and quality of life. J Urol 1996;155:1260-1264.
74. da Silva FC, Reis E, Costa T, Denis L. Quality of life in patients with prostatic cancer. A feasibility study. The Members of Quality of Life Committee of the EORTC Genitourinary Group. Cancer 1993;71(3 Suppl):1138-1142.
75. Watkins-Bruner D, Scott C, Lawton C, DelRowe J, Rotman M, Buswell L, Beard C, Cella D. RTOG's first quality of life study-RTOG 90-20: a phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 1995;33:901-906.
76. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J. The Functional Assessment of Cancer Therapy Scale: development and validation of the general measure. J Clin Oncol 1993;11:570-579.
77. Cella D. Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) measurement system, version 4. Chicago, IL: Center on Outcomes, Research and Education, Evanston Northwestern Healthcare and Northwestern University, 1997.
78. Patrick DL, Martin ML, Bushnell DM, Yalcin I, Wagner TH, Buesching DP. Quality of life of women with urinary incontinence: further development of the incontinence quality of life instrument (I-QOL). Urology 1999;53:71-76.
79. Haab F, Trockman BA, Zimmern PE, Leach GE. Quality of life and continence assessment of the artificial urinary sphincter in men with minimum 3.5 years of followup. J Urol 1997;158:435-439.